Home / Markets / Industries / Health Care
Monday, November 16, 2009
Abbott Laboratories Reports Positive Results on Niaspan
FOXBusiness
Abbott Laboratories (ABT) announced on Monday positive results of cholesterol drug Niaspan. The company said that patients who used Niaspan along with a statin had improvement in clogged arteries after 8 to 14 months.
The Arbiter 6 study, which was funded by Abbot, was conducted on 208 patients. Those patients also reported fewer major cardiac events, like heart attacks. The patients tested were at high risk for heart attack and were already taking statins to lower cholesterol.
Fox Business Video
-
-
Euro Debt Could Boost Gold
-
Feb 9, 2010
FOXBusiness.com LIVE
-
-
-
Health-Care Reform vs. Job Creation
-
Feb 9, 2010
Question of the Day
-
-
-
Ron Paul on Stimulus
-
Feb 9, 2010
Future of government bailouts?
-
-
-
U.S. No Longer the Space Explo...
-
Feb 9, 2010
Future of space program
-
-
-
Toyota Will Recover
-
Feb 9, 2010
Will the auto manufacturer bounce back?
-
Last 5 Stocks
- Ticker
- Company
- Price
- Change